Melanoma Resistance: A Bright Future for Academicians and a Challenge for Patient Advocates
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
In this issue of Mayo Clinic Proceedings , 2 complementary papers review recent advances in the contemporary therapy of melanoma 1 and provide a speculative synthesis 2 on the similarities between the mechanism protecting the fetus from an immune response by the mother and the evasion of host responses by metastatic melanoma. The first of these articles, by Shah and Dronca, 1 predicts a bright future for academicians and clinicians who will be responsible for evaluating and clinically applying multiple new strategies proposed to treat this devastating disease. That treatment will likely involve a flurry of new molecules and treatment modalities that are currently being developed. 1 These novel patient- and tumor-specific therapies are expected to target the hallmark features of cancer that promote cancer formation and progression (Table). 3 The second article, by Enninga et al, 2 discusses multiple mechanisms used by the placenta to protect itself and the fetus from the mother’s immune attack. Mechanisms similar to these can potentially be used by metastatic melanoma to evade the host response and immunotherapy. 2 The multiplicity of potential mechanisms listed 2 will secure the academic future for years to come as we attempt to resolve new methods for targeting immune modulation as a treatment for patients with melanoma. Unfortunately, the immediate future is not so bright for these patients currently available or developing treatment strategies are able to prolong life for only a few months before the disease relapses, modest improvements overall survival typically occur during periods in which the therapies, which are very expensive, produce toxic adverse effects. occurs melanoma multiple hinder older therapies. resistance not limited microenvironment, generate
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Holick, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmra070553 · Cited by 13,720
Melanin pigmentation in mammalian skin and its hormonal regulation
Slominski, A., Tobin, D. J., Shibahara, S., & Wortsman, J. (2004) · Physiological Reviews · doi:10.1152/physrev.00044.2003 · Cited by 2,015
Self-citationTumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Straussman, R., Morikawa, T., Shee, K., Barzily-Rokni, M., Qian, Z. R., Du, J., Davis, A., Mongare, M. M., Gould, J., Frederick, D. T., et al. (2012) · Nature · doi:10.1038/nature11183 · Cited by 1,771
Slominski, A., Wortsman, J., Luger, T., Paus, R., & Solomon, S. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.979 · Cited by 776
Self-citationSlominski (2012) · doi:10.1007/978-3-642-19683-6_1 · Cited by 461
Key role of CRF in the skin stress response system
Slominski, A. T., Zmijewski, M. A., Zbytek, B., Tobin, D. J., Theoharides, T. C., & Rivier, J. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1092 · Cited by 400
Self-citationSteroidogenesis in the skin: Implications for local immune functions
Slominski, A., Zbytek, B., Nikolakis, G., Manna, P. R., Skobowiat, C., Zmijewski, M., Li, W., Janjetovic, Z., Postlethwaite, A., Zouboulis, C. C., et al. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.02.006 · Cited by 369
Self-citationMelanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma
Brożyna, A. A., Jóźwicki, W., Carlson, J. A., & Slominski, A. T. (2013) · Human Pathology · doi:10.1016/j.humpath.2013.02.022 · Cited by 175
Self-citation
Cited by
Melanoma, Melanin, and Melanogenesis: The Yin and Yang Relationship
Slominski, R. M., Sarna, T., Płonka, P. M., Raman, C., Brożyna, A. A., & Slominski, A. T. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.842496 · Cited by 286
Self-citationTargeting Metalloenzymes for Therapeutic Intervention
Chen, A. Y., Adamek, R. N., Dick, B. L., Credille, C. V., Morrison, C. N., & Cohen, S. M. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00201 · Cited by 270
Melanin content in melanoma metastases affects the outcome of radiotherapy
Brożyna, A. A., Jóźwicki, W., Roszkowski, K., Filipiak, J., & Slominski, A. T. (2016) · Oncotarget · doi:10.18632/oncotarget.7528 · Cited by 208
Self-citationSlominski, A., Kim, T.-K., Brożyna, A. A., Janjetovic, Z., Brooks, D. L. P., Schwab, L. P., Skobowiat, C., Jóźwicki, W., & Seagroves, T. N. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.06.030 · Cited by 203
Self-citationSlominski, A. T., Brożyna, A. A., Zmijewski, M. A., Jóźwicki, W., Jetten, A. M., Mason, R. S., Tuckey, R. C., & Elmets, C. A. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.3 · Cited by 136
Self-citation
Metadata
- Authors
- Slominski, A. T., & Carlson, J. A.
- Venue
- Mayo Clinic Proceedings
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 89
- Issue
- 4
- Pages
- 429-433
- ISSN
- 0025-6196 (ISSN-L)
- OpenAlex
- W1992331783
- Cited by
- 127
- References
- 8
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Melanoma Resistance: A Bright Future for Academicians and a Challenge for Patient Advocates. https://app.cochat.ai/papers/10.1016/j.mayocp.2014.02.009
- The paper
- Slominski, A. T., & Carlson, J. A. (2014). Melanoma Resistance: A Bright Future for Academicians and a Challenge for Patient Advocates. Mayo Clinic Proceedings. https://doi.org/10.1016/j.mayocp.2014.02.009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.